Close Menu
Healthtost
  • News
  • Mental Health
  • Men’s Health
  • Women’s Health
  • Skin Care
  • Sexual Health
  • Pregnancy
  • Nutrition
  • Fitness
What's Hot

15 easy ways to get 20 grams of protein (Personal Trainer Guide)

June 29, 2025

Organ chip technology accurately predicts chemotherapy response to patients with esophageal adenocarcinoma

June 29, 2025

How Barefoot Workout can make you stronger, more athletic and stunning in injuries

June 29, 2025
Facebook X (Twitter) Instagram
  • About Us
  • Contact Us
  • Privacy Policy
  • Terms and Conditions
  • Disclaimer
Facebook X (Twitter) Instagram
Healthtost
SUBSCRIBE
  • News

    Organ chip technology accurately predicts chemotherapy response to patients with esophageal adenocarcinoma

    June 29, 2025

    Expansion of genetic code to mammalian cells using pseuduridine -modified codons

    June 29, 2025

    Discover a Dimmer Genetic switch that controls fetal growth

    June 28, 2025

    Who Scientific Advisory Group for the origin of new pathogenic reports for Sars-Cov-2 Origins

    June 28, 2025

    Exploring nervous reactions to mental exhaustion in healthy adults

    June 27, 2025
  • Mental Health

    Which one is right for you? – Talkspace

    June 27, 2025

    Do alternative treatments for bipolar disorder work? Guide based on evidence (2025)

    June 26, 2025

    Data reveals both challenges and positive trends

    June 16, 2025

    How to choose the best yoga teacher training in Rishikesh

    June 14, 2025

    Stress is the most common mental health problem – here is how technology could help manage

    June 11, 2025
  • Men’s Health

    How Barefoot Workout can make you stronger, more athletic and stunning in injuries

    June 29, 2025

    How I turned the chatgpt to my personal nutrition coach and you can also

    June 29, 2025

    Total human care is here: Help men look and feel great now and forever

    June 28, 2025

    Why men ignore sleep apnea (and what they really cost them) – talking about men’s health

    June 28, 2025

    Lessons from a survivor for prostate cancer

    June 26, 2025
  • Women’s Health

    Books I have recently read – The Fitnessista

    June 29, 2025

    Does it support your aesthetic travel your body and mind? Guide

    June 28, 2025

    Eating for real immune support this winter

    June 27, 2025

    What does public health really mean

    June 27, 2025

    How long do you have to expand after MTF? A complete driver to expand – Vuvatech

    June 25, 2025
  • Skin Care

    Sunburn First Aid -7 common mistakes you will regret later

    June 29, 2025

    What is happening first? The step by step guide to build a routine of skin care

    June 28, 2025

    DIY Vitamin C Cucumber The Eye Serum

    June 27, 2025

    Tips for Summer skin care for your best skin

    June 26, 2025

    How a crisis of ingredients led to the best physical form of our deodorant stick

    June 24, 2025
  • Sexual Health

    Can Koles really get chlamydia?

    June 28, 2025

    Overward Visitor and Student Health Insurance in Australia for visa holders

    June 27, 2025

    Disassociation of the latest testosterone treatment lines

    June 27, 2025

    We always know that orgasms were good for you. Now there is proof.

    June 26, 2025

    Josh Duhamel gets testosterone replacement treatment at 52

    June 25, 2025
  • Pregnancy

    AI helps the couple capture after 19 years and 15 IVF attempts

    June 29, 2025

    7 signs your gut can be out of balance

    June 29, 2025

    Helping parents prepare for birth with calm and trust

    June 28, 2025

    Better screen limits for kids: Expert driver for parents

    June 28, 2025

    What is prenatal ability?

    June 27, 2025
  • Nutrition

    25 best vegan taco recipes that are healthy, easy and full of flavor

    June 29, 2025

    Episode 004: Trust your truth against all logic with Angela de la Agua

    June 28, 2025

    Benefits for the health of CoQ10 you should be aware

    June 27, 2025

    Creatine Completion in Menopause: What does science say?

    June 27, 2025

    GLP-1 Enhance the Smoothie recipes push for weight loss

    June 26, 2025
  • Fitness

    15 easy ways to get 20 grams of protein (Personal Trainer Guide)

    June 29, 2025

    Review of the Heat Index: an approach based on evidence

    June 28, 2025

    Bodybuilding Legend Charles Glass’ 5 Favorite Movements Hamstring

    June 27, 2025

    7 Best energy gels 2025, per runners and dieticians

    June 26, 2025

    Different types of training and fitness courses

    June 25, 2025
Healthtost
Home»News»New drug combination doubles effectiveness in shrinking enlarged spleen in patients with myelofibrosis
News

New drug combination doubles effectiveness in shrinking enlarged spleen in patients with myelofibrosis

healthtostBy healthtostDecember 11, 2023No Comments3 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Reddit WhatsApp Email
New Drug Combination Doubles Effectiveness In Shrinking Enlarged Spleen In
Share
Facebook Twitter LinkedIn Pinterest WhatsApp Email

The combination of the JAK inhibitor ruxolitinib with the BCL-xL inhibitor navitoclax was twice as effective in reducing spleen enlargement – ​​a key indicator of clinical improvement – ​​compared with standard ruxolitinib monotherapy for adult patients with intermediate- or high-risk myelofibrosis, a rare cancer of the bone marrow, according to results of the Phase III TRANSFORM-1 trial reported by researchers from the University of Texas MD Anderson Cancer Center.

Data from the global, randomized, placebo-controlled clinical trial were presented today at the American Society of Hematology (ASH) 2023 Annual Meeting by Naveen Pemmaraju, MD, professor of Leukemia. At the time of the data cut-off, 63.2% of patients receiving ruxolitinib and navitoclax achieved a reduction in spleen volume of at least 35% within 24 weeks, compared with 31.5% of patients receiving ruxolitinib plus placebo; which meets the primary endpoint of the study.

By adding a second drug to an approved treatment, we were able to improve spleen volume reduction compared to the current standard of care. This is an important measure of the clinical benefits of this new drug combination, because treatments may be less effective when the spleen remains enlarged. If we can treat myelofibrosis earlier in the disease course, we may have an opportunity to affect overall disease modification, improve patient outcomes, and reduce symptom burden.”


Naveen Pemmaraju, MD, Professor of Leukemia

Currently, there are few drugs approved by the Food and Drug Administration to treat myelofibrosis. Available options provide patients with splenic and symptomatic improvement, but there remains a substantial unmet need for therapies that provide durable reduction in spleen size and other long-term clin. Allogeneic stem cell transplants are an effective treatment option, but not all patients qualify.

This international trial involved 252 patients with intermediate- or high-risk myelofibrosis and measurable splenomegaly who had not received prior JAK inhibitor treatment. The trial randomized 125 patients to receive the combination of navitoclax and ruxolitinib and 127 patients to receive ruxolitinib plus placebo. Most patients were male (57%) and the median age was 69.

The trial met its primary endpoint of spleen volume reduction at 24 weeks. Spleen volume reduction at any time was achieved by 77% of patients in the combination arm and 42% of patients in the control arm. The median time to first spleen volume reduction response was 12.3 weeks with the combination and 12.4 weeks with monotherapy. At 24 weeks, there were no significant differences between the groups on a myeloproliferative neoplasm symptom score, a secondary endpoint of the study.

Patients treated with the combination therapy had side effects that were manageable and consistent with previous trials. The most common treatment-related adverse events were thrombocytopenia, anemia, diarrhea, and neutropenia. Serious adverse events were experienced by 26% of patients in the combination arm and 32% in the control arm.

“This study marks a remarkable achievement in the field of myelofibrosis, as one of the first global first-line Phase III randomized combination clinical trials reported in our field,” said Pemmaraju. “This data set now opens the door for additional research and exploration of combination therapies to treat myelofibrosis and, importantly, highlights a potential new era of disease-modifying investigation for patients. Additional data from the TRANSFORM-1 study are being evaluated.”

The trial was funded by AbbVie. Pemmaraju receives research support from AbbVie.

Source:

University of Texas MD Anderson Cancer Center

combination doubles drug effectiveness enlarged myelofibrosis Patients shrinking spleen
bhanuprakash.cg
healthtost
  • Website

Related Posts

Organ chip technology accurately predicts chemotherapy response to patients with esophageal adenocarcinoma

June 29, 2025

Expansion of genetic code to mammalian cells using pseuduridine -modified codons

June 29, 2025

Discover a Dimmer Genetic switch that controls fetal growth

June 28, 2025

Leave A Reply Cancel Reply

Don't Miss
Fitness

15 easy ways to get 20 grams of protein (Personal Trainer Guide)

By healthtostJune 29, 20250

The acquisition of several proteins in your diet is vital to muscle repair, satiety and…

Organ chip technology accurately predicts chemotherapy response to patients with esophageal adenocarcinoma

June 29, 2025

How Barefoot Workout can make you stronger, more athletic and stunning in injuries

June 29, 2025

Books I have recently read – The Fitnessista

June 29, 2025
Stay In Touch
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
TAGS
Baby benefits body brain cancer care Day Diet disease exercise finds Fitness food Guide health healthy heart Life Loss Men mental Natural Nutrition Patients Pregnancy protein research reveals Review risk routine sex sexual Skin study Therapy Tips Top Training Treatment Understanding ways weight women Workout
About Us
About Us

Welcome to HealthTost, your trusted source for breaking health news, expert insights, and wellness inspiration. At HealthTost, we are committed to delivering accurate, timely, and empowering information to help you make informed decisions about your health and well-being.

Latest Articles

15 easy ways to get 20 grams of protein (Personal Trainer Guide)

June 29, 2025

Organ chip technology accurately predicts chemotherapy response to patients with esophageal adenocarcinoma

June 29, 2025

How Barefoot Workout can make you stronger, more athletic and stunning in injuries

June 29, 2025
New Comments
    Facebook X (Twitter) Instagram Pinterest
    • About Us
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Disclaimer
    © 2025 HealthTost. All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.